Patents by Inventor Kentaro Futatsugi

Kentaro Futatsugi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MORPHOLINE COMPOUNDS
    Publication number: 20110281854
    Abstract: Mineralocorticoid receptor antagonists (MRa), pharmaceutical compositions containing such inhibitors and the use of such inhibitors to treat, for example, diabetic nephropathy and hypertension in mammals, including humans.
    Type: Application
    Filed: May 10, 2011
    Publication date: November 17, 2011
    Inventors: Agustin Casimiro-Garcia, Kentaro Futatsugi, David W. Piotrowski
  • Substituted bicyclocarboxyamide compounds
    Patent number: 7964732
    Abstract: This invention provides a compound of the formula These compounds are useful for the treatment of disease conditions caused by overactivation of the VR1 receptor such as pain, or the like in mammal. This invention also provides a pharmaceutical composition comprising the above compound.
    Type: Grant
    Filed: November 9, 2007
    Date of Patent: June 21, 2011
    Assignee: Pfizer Inc.
    Inventors: Koji Ando, Andrew Anthony Calabrese, Matthew Alexander James Duncton, Kentaro Futatsugi, Misato Hirano, Satochi Nagayama
  • GPR 119 MODULATORS
    Publication number: 20100285145
    Abstract: Compounds of Formula (I) that modulate the activity of the G-protein-coupled receptor GPR119 and their uses in the treatment of diseases linked to the modulation of the G-protein-coupled receptor GPR119 in animals are described herein.
    Type: Application
    Filed: May 6, 2010
    Publication date: November 11, 2010
    Inventors: Etzer Darout, Michael P. DeNinno, Kentaro Futatsugi, Cristiano Guimaraes, Bruce A. Lefker, Vincent Mascitti, Kim F. McClure, Michael J. Munchhof, Ralph P. Robinson
  • Substituted Bicyclocarboxyamide Compounds
    Publication number: 20100267769
    Abstract: This invention provides a compound of the formula These compounds are useful for the treatment of disease conditions caused by overactivation of the VR1 receptor such as pain, or the like in mammal. This invention also provides a pharmaceutical composition comprising the above compound.
    Type: Application
    Filed: November 9, 2007
    Publication date: October 21, 2010
    Inventors: Koji Ando, Andrew Anthony Calabrese, Matthew Alexander James Duncton, Kentaro Futatsugi, Misato Hirano, Satochi Nagayama